Eastwood Bio-Medical Canada Inc. (TSXV:EBM)

Market Cap	68.89M +5.3%
Revenue (ttm)	594.57K -9.0%
Net Income	-411.84K
EPS	-0.01
Shares Out	68.89M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	5,184
Average Volume	6,767
Open	1.000
Previous Close	1.000
Day's Range	0.910 - 1.000
52-Week Range	0.295 - 1.100
Beta	0.02
RSI	61.68
Earnings Date	Feb 27, 2026

About TSXV:EBM

Eastwood Bio-Medical Canada Inc. markets and distributes natural health products under the Eleotin brand in Canada, the United States, and Asia. The company distributes Eleotin, which provides natural remedies for metabolic disorders, such as blood glucose disorders, hypertension, and obesity. Its licensed products include Eleotin A 700 for the treatment for spleen deficiency, lack of appetite, and fatigue; Eleotin AL88 for laxative; Eleotin Cal20 for bone and teeth maintenance; Eleotin V3D for development and maintenance of bones, teeth, and g...

• Industry: Food Distribution
• Sector: Consumer Staples
• Founded: 2010
• Country: Canada
• Stock Exchange: TSX Venture Exchange
• Ticker Symbol: EBM

Financial Performance

In fiscal year 2024, TSXV:EBM's revenue was 702,076, a decrease of -19.11% compared to the previous year's 867,936. Losses were -455,870, -16.60% less than in 2023.